Jump to Main Content
- Liu, Ye V., et al. Show all 7 Authors
- Vaccine 2017 v.35 no.12 pp. 1586-1589
- Middle East respiratory syndrome coronavirus; adjuvants; mice; nanoparticles; neutralizing antibodies; vaccination; vaccines; virion
- ... The Middle East respiratory syndrome coronavirus (MERS-CoV) was first discovered in late 2012 and has gone on to cause over 1800 infections and 650 deaths. There are currently no approved therapeutics or vaccinations for MERS-CoV. The MERS-CoV spike (S) protein is responsible for receptor binding and virion entry to cells, is immunodominant and induces neutralizing antibodies in vivo, all of which ...
- PubMed Central: